Skip to content
Search

Latest Stories

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Funding for Pharmacy First is set to expire at the beginning of April, with no confirmed extension beyond that.

Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.


The National Pharmacy Association (NPA) has confirmed that funding for Pharmacy First, launched last year, is set to expire at the beginning of April, with no commitment yet for future funding.

“This is deeply worrying, given the important role that Pharmacy First plays in supporting local healthcare delivery and alleviating pressure on our overburdened NHS,” Morgan said.

Her letter, signed by over 50 MPs, also raised alarm over the financial struggles threatening Britain’s pharmacies.

She warned that many face imminent closure due to “a deadly combination of a litany of financial pressures and an ongoing lack of support and clarity from the government.”

"Pharmacies play an essential role in the community. This cornerstone of primary care, however, is increasingly under threat,” Morgan said.

Citing recent NPA analysis, Morgan highlighted that up to 1,000 pharmacies could close within the next few years, with 900 closures expected by 2027 if current trends persist.

The association warned that some areas could lose 30% of their pharmacies, leading to an explosion of “pharmacy deserts.”

The NPA pointed to a 40% real-terms funding cut since 2015 as a key factor in the sector’s struggles.

Morgan stressed that the situation is set to worsen in the coming months, with pharmacies facing further financial strain due to the planned rise in National Insurance contributions and the increase in business rates, which affect high street retailers including pharmacies.

"Moreover, many pharmacies are already operating at a loss on many prescription drugs, essentially subsidising the NHS at a time when their own financial sustainability is in jeopardy,” she added.

The MP further criticised the government for failing to confirm funding rates for the current financial year, which ends in just a few weeks.

“This severity of a delay in contracting is unacceptable and adds further strain to an already struggling sector,” she stated.

Morgan urged the government to urgently confirm funding and establish a long-term contract that puts community pharmacies “back on a path to survival and, ultimately, success.”

She noted that supporting the sector is vital to achieving the government’s aim of shifting more care into the community.

“We cannot afford to lose more pharmacies from our high streets, particularly at a time when access to healthcare is becoming increasingly difficult for many people across the country,” she added.

Helen Morgan's letter to Health Secretary, Wes Streeting.Helen Morgan's letter to Health Secretary, Wes Streeting.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less